SAVIMS

Other scientific evidence

COVID-19, Ivermectin, Other scientific evidence, Treatment, Viral illnesses

Legal Victory for Ivermectin Access in South Africa

Reference: The NewERA. (2021, April 8). SAHPRA destroyed in court – Ivermectin available. Summary: On 8 April 2021, a significant court ruling declared that the South African Health Products Regulatory Authority (SAHPRA) could no longer restrict access to Ivermectin, a treatment believed to help with HIV and COVID-19. The High Court found SAHPRA’s actions to […]

COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Why COVID-19 is not so spread in Africa: How does Ivermectin affect it?

Reference: Taniokal, H., Taniokal, S., & Kaga, K. (2021). Why COVID-19 is not so spread in Africa: How does Ivermectin affect it? medRxiv. https://doi.org/10.1101/2021.03.26.21254377 Summary: This article explores the low incidence of COVID-19 in Africa, investigating the potential effects of ivermectin, a treatment for onchocerciasis, on morbidity and mortality rates. A statistical analysis was conducted

COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Global trends exploring Ivermectin’s Potential in COVID-19 Treatment

Reference: Yagisawa, M., Foster, P. J., Hanaki, H., & Ōmura, S. (2021). Global trends in clinical studies of ivermectin in COVID-19. The Japanese Journal of Antibiotics, 74(1), 44-75. Summary: The article reviews global clinical studies of ivermectin as a potential treatment for COVID-19. Initially, the outbreak was poorly communicated by the Chinese government, leading to

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Understanding mRNA COVID-19 Vaccines

Reference: Centres for Disease Control and Prevention. (2021, March 4). Understanding mRNA COVID-19 vaccines. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html Summary: mRNA vaccines represent a novel approach to immunisation against infectious diseases, including COVID-19. They work by instructing cells to produce a harmless piece of the virus’s spike protein, eliciting an immune response without introducing the live virus. This process

COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Summary of the BIRD Recommendation on Ivermectin for Covid-19

Reference: Bryant, A., Lawrie, T. A., Dowswell, T., Fordham, E., Hill, S., Mitchell, S., & Tham, T. (2021). The BIRD recommendation on the use of ivermectin for Covid-19: Proceedings and conclusions of the British Ivermectin Recommendation Development meeting held on the 20th February 2021 in Bath, United Kingdom. Evidence-Based Consultancy Medicine Ltd. Summary: The British

Nutritional supplements, Other scientific evidence, Resource Type, Treatment

The Health Benefits of Tocotrienols: An Underappreciated Vitamin E Isomer

Reference: Musa, A. F. (2021). Tocotrienol: An underrated isomer of vitamin E in health and diseases. In Vitamin E in Health and Disease – Interactions, Diseases and Health Aspects. IntechOpen. https://doi.org/10.5772/intechopen.96451 Summary: This chapter explores tocotrienols, an often-overlooked form of vitamin E, highlighting their significant health benefits. Tocotrienols, found abundantly in palm oil, possess superior

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Efficacy and Safety of Janssen’s Ad26.COV2.S Vaccine for COVID-19

Reference: FDA. (2021). Vaccines and related biological products advisory committee meeting: February 26, 2021. Janssen Ad26.COV2.S vaccine for the prevention of COVID-19. FDA Briefing Document. Summary: The FDA briefing document details the Emergency Use Authorization (EUA) request submitted by Janssen Biotech for the Ad26.COV2.S vaccine aimed at preventing COVID-19. This single-dose adenovirus vector vaccine demonstrated

COVID-19, Ivermectin, News, Other scientific evidence, Treatment, Viral illnesses

BIRD Recommendation on Ivermectin for Covid-19

Reference: British Ivermectin Recommendation Development. (2021). The BIRD recommendation on the use of ivermectin for Covid-19: Executive summary. Proceedings and conclusions of the British Ivermectin Recommendation Development meeting. Summary: The British Ivermectin Recommendation Development (BIRD) meeting, held on 20th February 2021 in Bath, aimed to evaluate ivermectin’s efficacy in treating and preventing Covid-19, especially in

COVID-19, Covid-19 vaccines, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Case Investigation Form for AEFI and AESI

Reference: Author. (2021). Case investigation form for AEFI serious, severe, cluster, AESI for all vaccines including COVID-19. Retrieved from [insert URL if available] Summary: The document is a Case Investigation Form designed to report Adverse Events Following Immunisation (AEFI) and Adverse Events of Special Interest (AESI) for all vaccines, including COVID-19. It is intended for

COVID-19, Ivermectin, Other scientific evidence, Treatment, Viral illnesses

Efficacy of Ivermectin in COVID-19 Treatment FLCCC

Reference: Kory, P., Meduri, G. U., Iglesias, J., Varon, J., & Marik, P. E. (2021). Review of the emerging evidence supporting the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. Front-Line COVID-19 Critical Care Alliance. Summary: This article by the Front Line COVID-19 Critical Care Alliance reviews the growing evidence supporting ivermectin’s effectiveness

Scroll to Top